as 12-18-2024 10:30am EST
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Founded: | 2016 | Country: | United States |
Employees: | N/A | City: | AUSTIN |
Market Cap: | 894.1M | IPO Year: | 2021 |
Target Price: | $4.38 | AVG Volume (30 days): | 3.6M |
Analyst Decision: | Hold | Number of Analysts: | 18 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.94 | EPS Growth: | N/A |
52 Week Low/High: | $1.50 - $13.45 | Next Earning Date: | 11-07-2024 |
Revenue: | $5,594,117,000 | Revenue Growth: | 54.10% |
Revenue Growth (this year): | 41.65% | Revenue Growth (next year): | 10.30% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
McLoughlin Karen | AGL | Director | Dec 13 '24 | Buy | $2.20 | 25,000 | $55,085.00 | 73,166 | |
Battaglia Silvana | AGL | Director | Dec 11 '24 | Buy | $2.01 | 25,062 | $50,269.36 | 66,144 | |
Wulf John William | AGL | Director | Dec 5 '24 | Buy | $2.18 | 45,000 | $98,145.00 | 206,133 | |
MCKENZIE DIANA | AGL | Director | Nov 25 '24 | Buy | $2.24 | 20,000 | $44,962.50 | 51,319 |
AGL Breaking Stock News: Dive into AGL Ticker-Specific Updates for Smart Investing
Argus Research
4 hours ago
Argus Research
a day ago
Argus Research
2 days ago
Argus Research
6 days ago
TipRanks
a month ago
Business Wire
a month ago
GuruFocus.com
a month ago
Zacks
a month ago
The information presented on this page, "AGL agilon health inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.